Do novel adipokines play a causative or only modulating role in the pathogenesis of obesity and metabolic disorders?

  Vol. 33 (1) 2012 Neuro endocrinology letters Journal Article   2012; 33(1): 11-15 PubMed PMID:  22467105    Citation  Keywords:  Adipocytes:metabolism, Adipokines, Adipose Tissue:metabolism, Humans, Metabolic Diseases, Obesity:metabolism,.   

: Adipose tissue is an endocrine and paracrine organ that releases a large number of bioactive mediators. Approximately 100 adipokines have been identified including cytokines, chemokines, growth factors and enzymes. The use of adipoproteomic analyses resulted in new findings and, in consequence, the number of new adipokines is rising rapidly. Novel adipokines such as visfatin, vaspin and omentin were discovered about five years ago. Visfatin and vaspin production and secretion take place in adipocytes, but omentin comes from the stromal cells of adipose tissue. Several differences are noticeable between these adipokines especially in correlation with obesity as visfatin and vaspin serum levels increase in obese subjects while omentin serum levels decrease. It has been suggested that these adipokines act as insulin-sensitizers/insulin-mimetics. Increasing number of publications reporting the role of new adipokines does not allow to assess clearly the influence of those adipokines on the pathogenesis of obesity.

 Full text PDF